Pyxis Oncology is transforming the lives of patients with cancer by advancing our differentiated portfolio of biologics that specifically target tumor cells and overcome immune suppression. We believe that antibody-drug conjugates (ADCs) and immunotherapies have the potential to address difficult-to-treat cancers and improve patient outcomes.
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Total raised: $174M
Founded date: 2019
Founders name: ZE-QI (ZQ) XU
Investors 5
| Date | Name | Website |
| - | Agent Capi... | agentcapit... |
| - | RA Capital... | racap.com |
| - | Skydeck Ca... | skydeckllc... |
| - | Perceptive... | perceptive... |
| - | HBM Partne... | hbmpartner... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 31.03.2021 | Series B | $152M | - |
| 18.07.2019 | Series A | $22M | - |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | ZE-QI (ZQ) | XU | Chairman a... | linkedin.c... | - | - |
Mentions in press and media 16
| Date | Title | Description | Source |
| 13.03.2024 | Pyxis Oncology Expands Board of Directors with Appointment o... | - | globenewsw... |
| 07.03.2024 | Pyxis Oncology to Present at Leerink Global Biopharma Confer... | - | globenewsw... |
| 05.03.2024 | Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 P... | - | globenewsw... |
| 21.03.2023 | This VC built a lab to make building biotech startups easier | When you think of life sciences and biotech hubs in the U.S., where do you travel to in your mind? B... | techcrunch... |
| 29.03.2022 | Biosion licenses BSI-060T (anti-Siglec-15) to Pyxis Oncology | - Pyxis Oncology will be responsible for development and commercialization of BSI-060T (now referred... | en.prnasia... |
| 31.03.2021 | Pyxis Oncology closes $152M Series B | Pyxis Oncology, a developer of therapeutics for difficult-to-treat cancers, has raised a $152 millio... | pitchbook.... |
| 30.03.2021 | After Pfizer cancer deal, Pyxis Oncology nabs a hefty $152M ... | It’s been a nice month for Pyxis Oncology: After penning a major licensing deal with Pfizer, the sta... | fiercebiot... |
| 30.03.2021 | Pyxis Oncology Raises $152M Series B Round | CAMBRIDGE, MA, Pyxis Oncology today announced the closing of a $152 million Series B financing. &... | vcnewsdail... |
| 30.03.2021 | After Pfizer cancer deal, Pyxis Oncology nabs a hefty $152M ... | It’s been a nice month for Pyxis Oncology: After penning a major licensing deal with Pfizer, the sta... | fiercebiot... |
| 30.03.2021 | ARIX BIOSCIENCE PLC Arix leads USD152 million Series B fina... | Arix Bioscience PLC (ARIX) Arix leads USD152 million Series B financing for Pyxis Oncology 30-March-... | marketscre... |
Show more